YCCL — Yasons Chemex Care Income Statement
0.000.00%
- IN₹297.28m
- IN₹437.37m
- IN₹692.43m
- 22
- 55
- 22
- 20
Annual income statement for Yasons Chemex Care, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 194 | 178 | 251 | 368 | 692 |
Cost of Revenue | |||||
Gross Profit | 18.8 | 25.4 | 24.9 | 12.6 | 43.2 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 180 | 160 | 233 | 364 | 671 |
Operating Profit | 14.2 | 17.7 | 17.5 | 3.91 | 21.8 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 15.8 | 18.2 | 25.1 | 42.1 | 18 |
Provision for Income Taxes | |||||
Net Income After Taxes | 11.6 | 12.5 | 19.5 | 34.3 | 12.5 |
Net Income Before Extraordinary Items | |||||
Net Income | 11.6 | 12.5 | 19.5 | 34.3 | 12.5 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 11.6 | 12.5 | 19.5 | 34.3 | 12.5 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.598 | 0.649 | 1.01 | 1.78 | 0.709 |